Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.60 | 4.60 | 0.00 |
Shares | 95.40 | 95.40 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.24 | 24.03 |
Price to Book | 3.77 | 4.52 |
Price to Sales | 2.36 | 3.29 |
Price to Cash Flow | 16.47 | 15.89 |
Dividend Yield | 1.16 | 1.22 |
5 Years Earnings Growth | 12.88 | 12.39 |
Name | Net % | Category Average |
---|---|---|
Technology | 42.40 | 26.69 |
Healthcare | 27.43 | 16.36 |
Industrials | 18.91 | 11.87 |
Financial Services | 3.29 | 13.48 |
Consumer Defensive | 3.18 | 8.05 |
Communication Services | 2.54 | 7.95 |
Basic Materials | 2.26 | 4.33 |
Number of long holdings: 47
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 5.29 | 409.34 | -1.02% | |
Merck&Co | US58933Y1055 | 3.92 | 130.37 | +2.19% | |
NVIDIA | US67066G1040 | 3.51 | 905.54 | -1.72% | |
SAP | DE0007164600 | 3.47 | 174.360 | +1.68% | |
UCB | BE0003739530 | 3.37 | 119.90 | +0.50% | |
AstraZeneca | GB0009895292 | 3.33 | 12,118.0 | +0.56% | |
ASML Holding | NL0010273215 | 3.23 | 854.20 | +0.90% | |
Prysmian | IT0004176001 | 3.06 | 52.8600 | +1.58% | |
Edwards Lifesciences | US28176E1082 | 3.06 | 85.85 | +0.89% | |
Xylem | US98419M1009 | 3.05 | 140.03 | +0.60% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Ibercaja Seleccion Renta Internacio | 1.82B | 2.79 | 0.34 | 1.61 | ||
Ibercaja Gestion Garantizado 6 FI | 1.73B | 0.87 | -2.16 | -0.42 | ||
Ibercaja Gestion Garantizado 5 FI | 1.57B | 0.94 | -1.16 | 0.47 | ||
ES0146794005 | 1.06B | 2.13 | 0.00 | - | ||
Ibercaja Mixto Flexible 15 A FI | 961.94M | 2.74 | 1.19 | 1.41 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review